December 5, 2017 : DCMS #374

DISASTERS AVERTED — Near Miss Case Studies

How Do You Discuss Vitamins?

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Aaron Vinik Part 5, Wonder Drug: SGLT-2 Inhibitor and GLP-1 Agonist

HOMERUN SLIDES — Great Clinical Presentation Highlights

Diabetes 2017 Part 4

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #102: Pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD) Part 4

MOST POPULAR ARTICLES OF THE MONTH

#1 1-Hour Post-Prandial Glucose Predicts Risk For Type 2 Diabetes
#2 Awareness of Type 3C Diabetes and Why It Is Misdiagnosed
#3 Type 1 Cured in Mice

This week, we want to help you simplify your selection of injectables for patients. While most patients often think that an injection is always insulin, we know that is not true. We also have GLP-1 analogs, as well as combinations of these products, so in our Homerun Slides, we make your life easier by sharing an updated presentation on what is available and how they are different.

Dave Joffe

Editor-in-chief

So many of my patients who have insulin resistance, type 1 or type 2 diabetes with hyperglycemia and/or obesity have vitamin D or vitamin B12 deficiency. Often they have never had their levels checked or, if they have, were diagnosed with either or both vitamin D deficiency and vitamin B12 deficiency and do not take their prescribed vitamins. Why?

In part 5 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the need to continue research into drugs such as SGLT-2s because breakthroughs may possibly be found in these medications.

In this week’s Homerun Slides, medication trial results, long-acting insulins, and treating prediabetes.

Hypertriglyceridemia and low HDL cholesterol, increased risk of type 2 diabetes: Under fasting conditions, the liver of subjects with NAFLD overproduces triglyceride-enriched VLDL particles despite hyperinsulinemia when compared to equally obese subjects without NAFLD. Insulin normally decreases production of VLDL by inhibiting adipose tissue lipolysis, and by directly suppressing hepatic production of VLDL.

Study finds diabetes complications and mortality may be better predicted with elevated 1-hour blood glucose levels compared with 2-hour blood glucose levels.

Diabetes has long been divided into type 1 and type 2. But a third type has entered the mix — and we aren’t diagnosing it correctly.

Ralph DeFronzo and his researchers at UT Health at San Antonio announced that they have cured type 1 diabetes.